A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

The aim of the study was to assess the toxicity and the clinical activity of biweekly oxaliplatin in combination with infusional 5-fluorouracil (5-FU) and folinic acid (FA) administered every 2 weeks (FOLFOX-4 regimen) in patients with advanced gastric cancer (AGC). A total of 61 previously untreate...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vita, F, Orditura, M, Matano, E, Bianco, R, Carlomagno, C, Infusino, S, Damiano, V, Simeone, E, Diadema, M R, Lieto, E, Castellano, P, Pepe, S, De Placido, S, Galizia, G, Di Martino, N, Ciardiello, F, Catalano, G, Bianco, A R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362040/
https://www.ncbi.nlm.nih.gov/pubmed/15856038
http://dx.doi.org/10.1038/sj.bjc.6602573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362040/
https://www.ncbi.nlm.nih.gov/pubmed/15856038
http://dx.doi.org/10.1038/sj.bjc.6602573

Ejemplares similares